Genetic Testing Underused for GI Cancers
Although Lynch syndrome is almost as prevalent as hereditary breast and ovarian cancer (HBOC), twice as many patients are undergoing testing for... Read More
Gene ‘Signature’ Could Lead to Early Cancer Test
Researchers have found a genetic “signature” common to five different types of cancer and hope it might be a step towards an... Read More
Mismatch Repair-Deficient GI Tumors Respond to Anti–PD-1
Understanding mismatch repair could help ID stomach cancer patients most likely to respond to immunotherapy.
Neoadjuvant chemo underused in patients with advanced gastric
Neoadjuvant chemotherapy (NAC) remains underused in patients with advanced gastric cancer, despite evidence that it does not worsen perioperative outcomes, U.S. researchers... Read More
Study uncovers inherited genetic susceptibility across 12 cancer types
Study suggests BRCA mutations and other genetic factors may raise risk of stomach cancer.
Pfizer and Merck KGaA commence late-stage trials of avelumab in gastric cancers
The immunotherapy avelumab will be tested in gastric cancer.
Study Discovers a Cause of Multiple Resistance to Cancer Chemotherapy
A new study finds a cause of multiple resistance in cancer chemotherapy: “We have found that 10% of colon and stomach tumors... Read More
Dietary Factors Linked With Gastric Cancer Risk Identified
Consumption of total fruit and white vegetables, as well as other dietary factors, may contribute to risk of gastric cancer, according to a... Read More
Targeted therapy for gastric cancer possible
Genomic fingerprint can highlight which breast, ovarian, pancreatic and gastric cancers are likely to respond to treatment.
Researchers uncover biomarker that may help predict stomach cancer survival
In a new study published in The American Journal of Pathology, scientists say they have identified a biomarker in patients with stomach cancer that... Read More
